10x Genomics shares are trading lower after Wolfe Research downgraded the stock from Outperform to Peer Perform.
Portfolio Pulse from Benzinga Newsdesk
10x Genomics shares are trading lower after Wolfe Research downgraded the stock from Outperform to Peer Perform.
June 27, 2024 | 2:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
10x Genomics shares are trading lower following a downgrade by Wolfe Research from Outperform to Peer Perform.
The downgrade by Wolfe Research is likely to negatively impact investor sentiment and lead to a short-term decline in 10x Genomics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100